Tobacco Products
FDA’s Center for Tobacco Products (CTP) works to ensure a healthier life for every family.
Latest Updates from the Center for Tobacco Products
FDA Authorizes Marketing of Four Oral Tobacco Products
Research shows a low likelihood that youth, non-smokers, or former smokers would initiate or reinitiate tobacco use with these products.
FDA Permits Marketing of E-cigarette Products
FDA authorized the marketing of three new tobacco products, marking the first set of ENDS products ever to be authorized through the PMTA pathway.
FDA Warns Companies That Ignore Marketing Denial Orders
All new tobacco products sold, distributed, or imported in the U.S. without FDA authorization are marketed unlawfully and risk enforcement.
September 9, 2020 Premarket Review Submission Deadline
FDA created a new webpage to provide manufacturers and importers with a single location for information and resources related to tobacco product applications for deemed new tobacco products, which were due by September 9, 2020. For tips, resources, and the latest information specific to these applications, visit the new webpage.
Learn MoreTobacco Education Resources for Parents and Teachers
As youth e-cigarette use remains a public health crisis, it is important that parents and educators have access to resources to learn more and to start an honest conversation with teens about the dangers of youth tobacco use. FDA has free resources available, including videos, infographics, posters, and fact sheets.
Learn moreContact CTP
1-877-287-1373 (9am - 4pm ET)
For General Inquiries: AskCTP@fda.hhs.gov
Center for Tobacco Products
Food and Drug Administration
10903 New Hampshire Avenue
Document Control Center
Building 71, Room G335
Silver Spring, MD 20993-0002